Literature DB >> 20143471

Role of RECK methylation in gastric cancer and its clinical significance.

Yun-Yi Du1, Dong-Qiu Dai, Zhi Yang.   

Abstract

AIM: To investigate the relation between RECK methylation and clinicopathological characteristics of gastric cancer patients and evaluate the role of RECK methylation in peritoneal metastasis of gastric cancer.
METHODS: Methylation of RECK gene in 40 paired samples of gastric cancer and its corresponding adjacent normal mucosa, lymph nodes and peritoneal irrigation fluid was detected by methylation-specific polymerase chain reaction.
RESULTS: Aberrant methylation of RECK gene was detected in 27.5% (11/40) of the adjacent normal mucosa samples, in 47.5% (19/40) of gastric cancer samples, in 57.1% (12/21) of the lymph node samples, and in 35% (14/40) of peritoneal irrigation fluid samples, respectively, with a significant difference between the adjacent normal mucosa and lymph node samples (P = 0.023). Presence of RECK methylation in the primary tumor samples was significantly correlated with tumor invasion (P = 0.023). The accuracy of RECK methylation in peritoneal lavage fluid samples for the diagnosis of peritoneal metastasis of gastric cancer was 72.5% (26/40), with a sensitivity of 66.7% (6/9) and a specificity of 74.2% (23/31).
CONCLUSION: Aberrant methylation of RECK gene may provide useful information for the early diagnosis and treatment of peritoneal metastasis of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143471      PMCID: PMC2825339          DOI: 10.3748/wjg.v16.i7.904

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  Gene silencing in cancer in association with promoter hypermethylation.

Authors:  James G Herman; Stephen B Baylin
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

2.  Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.

Authors:  Sang Yong Song; Hee Jung Son; Eunsook Nam; Jong Chul Rhee; Chaehwa Park
Journal:  Eur J Cancer       Date:  2005-12-01       Impact factor: 9.162

3.  CpG island methylation in premalignant stages of gastric carcinoma.

Authors:  G H Kang; Y H Shim; H Y Jung; W H Kim; J Y Ro; M G Rhyu
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

4.  Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.

Authors:  Carla Oliveira; Sérgia Velho; Enric Domingo; Ana Preto; Robert M W Hofstra; Richard Hamelin; Hiroyuki Yamamoto; Raquel Seruca; Simo Schwartz
Journal:  Oncogene       Date:  2005-11-17       Impact factor: 9.867

5.  Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.

Authors:  Hui-Chiu Chang; Chun-Yu Cho; Wen-Chun Hung
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

6.  Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.

Authors:  Huang-Chou Chang; Chun-Yu Cho; Wen-Chun Hung
Journal:  Cancer Sci       Date:  2007-02       Impact factor: 6.716

Review 7.  RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling.

Authors:  Makoto Noda; Junseo Oh; Rei Takahashi; Shunya Kondo; Hitoshi Kitayama; Chiaki Takahashi
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

8.  Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.

Authors:  C Takahashi; Z Sheng; T P Horan; H Kitayama; M Maki; K Hitomi; Y Kitaura; S Takai; R M Sasahara; A Horimoto; Y Ikawa; B J Ratzkin; T Arakawa; M Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

9.  Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.

Authors:  Chun-Yu Cho; Jui-Ho Wang; Hui-Chiu Chang; Chong-Keng Chang; Wen-Chun Hung
Journal:  J Cell Physiol       Date:  2007-10       Impact factor: 6.384

10.  Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.

Authors:  K Katsuragi; M Yashiro; T Sawada; H Osaka; M Ohira; K Hirakawa
Journal:  Br J Cancer       Date:  2007-07-31       Impact factor: 7.640

View more
  17 in total

1.  Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.

Authors:  Reza Mousavi Ardehaie; Shahriar Hashemzadeh; Shahin Behrouz Sharif; Morteza Ghojazadeh; Ladan Teimoori-Toolabi; Ebrahim Sakhinia
Journal:  Bioengineered       Date:  2017-01-31       Impact factor: 3.269

Review 2.  DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.

Authors:  Yuji Toiyama; Yoshinaga Okugawa; Ajay Goel
Journal:  Biochem Biophys Res Commun       Date:  2014-08-13       Impact factor: 3.575

3.  Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma.

Authors:  Xiong-Xiong Lu; Shu-Min Zhang; Yuan Fang; Zheng-Ting Wang; Jun-Jie Xie; Qian Zhan; Xia-Xing Deng; Hao Chen; Jia-Bin Jin; Cheng-Hong Peng; Hong-Wei Li; Bai-Yong Shen
Journal:  Tumour Biol       Date:  2013-06-08

4.  DNA methylation of NDRG2 in gastric cancer and its clinical significance.

Authors:  Xiaojing Chang; Zhenhua Li; Jinguo Ma; Peng Deng; Shuanglong Zhang; Yu Zhi; Jing Chen; Dongqiu Dai
Journal:  Dig Dis Sci       Date:  2012-09-26       Impact factor: 3.199

5.  Promoter hypermethylation of the RECK gene is associated with its low expression and poor survival of esophageal squamous cell carcinoma.

Authors:  Jing Zhu; Yang Ling; Yun Xu; Mingzhu Lu; Yongping Liu; Changsong Zhang
Journal:  Oncol Lett       Date:  2017-01-27       Impact factor: 2.967

6.  MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.

Authors:  Juan Xie; Zhi-Hui Tan; Xia Tang; Ming-Shu Mo; Yan-Ping Liu; Run-Liang Gan; Yi Li; Li Zhang; Guo-Qing Li
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

7.  Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.

Authors:  Kamdeo K Pramanik; Abhay K Singh; Manzar Alam; Tanushree Kashyap; Prajna Mishra; Aditya K Panda; Ratan K Dey; Ajay Rana; Siddavaram Nagini; Rajakishore Mishra
Journal:  Tumour Biol       Date:  2016-09-30

Review 8.  DNA and histone methylation in gastric carcinogenesis.

Authors:  Danielle Queiroz Calcagno; Carolina Oliveira Gigek; Elizabeth Suchi Chen; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

Review 9.  Role of microRNAs in gastric cancer.

Authors:  Hideyuki Ishiguro; Masahiro Kimura; Hiromitsu Takeyama
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

10.  Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.

Authors:  Lin Lei; Yaping Huang; Wenrong Gong
Journal:  Mol Cell Biochem       Date:  2013-10-27       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.